Valuation : DexCom, Inc.

Market Cap 33.85B 29.2B 27.51B 25.06B 46.84B 3,197B 47.19B 326B 126B 1,635B 127B 124B 5,370B P/E 2026 *
36x
P/E 2027 * 30.2x
Enterprise Value 33.08B 28.54B 26.89B 24.5B 45.79B 3,125B 46.13B 318B 124B 1,598B 124B 122B 5,249B EV / Sales 2026 *
6.33x
EV / Sales 2027 * 5.65x
Free-Float
91.27%
Yield 2026 *
-
Yield 2027 * -
1 day-0.14%
1 week+0.16%
Current month-1.79%
1 month+2.43%
3 months+22.89%
6 months+22.37%
Current year+34.74%
1 week 88.82
Extreme 88.825
92.34
1 month 82.09
Extreme 82.09
92.59
Current year 56.72
Extreme 56.72
92.59
1 year 54.11
Extreme 54.11
92.59
3 years 54.11
Extreme 54.11
142
5 years 54.11
Extreme 54.11
164.86
10 years 10.66
Extreme 10.655
164.86
Manager TitleAgeSince
Chief Executive Officer 47 31/12/2025
Director of Finance/CFO 46 18/03/2021
Chief Tech/Sci/R&D Officer - 30/04/2024
Director TitleAgeSince
Chairman 68 29/07/2018
Director/Board Member 67 19/11/2009
Director/Board Member 47 31/12/2025
Date Insider Type Main position Quantity % Market Cap. Importance
27/08/26 Sell

Head of Human Resources

-2,565 0.0007%
22/08/26 Tax

General Counsel

-1,451 0.0004%
22/08/26 Tax

Chief Financial Officer

-1,451 0.0004%
Change 5-day change 1-year change 3-year change Capi.($)
-0.04%+0.16%+13.32%-10.86% 33.85B
-1.56%-2.43%-17.63%+7.93% 191B
+0.23%+2.71%+0.17%+15.22% 118B
+0.25%+4.98%+14.26%+95.07% 64.19B
+0.16%-2.02%+26.41%+50.66% 51.49B
-0.42%-0.95%-1.72%-31.71% 51.08B
-0.17%+4.01% - - 31.85B
-0.38%-1.43%+37.04%-15.49% 24.11B
-0.06%-4.06%-7.43%+11.58% 22.96B
-1.06%-2.29%-6.12%+1.78% 22.46B
Average -0.40%-1.09%+6.48%+13.80% 61.11B
Weighted average by Cap. -0.62%-1.98%-0.22%+17.21%

Financials

2026 *2027 *
Net sales 5.23B 4.51B 4.25B 3.87B 7.24B 494B 7.29B 50.32B 19.53B 253B 19.64B 19.21B 830B 5.8B 5B 4.71B 4.29B 8.03B 548B 8.09B 55.8B 21.66B 280B 21.78B 21.3B 920B
Net income 974M 841M 792M 721M 1.35B 92.04B 1.36B 9.37B 3.64B 47.06B 3.66B 3.58B 155B 1.15B 991M 934M 851M 1.59B 109B 1.6B 11.05B 4.29B 55.49B 4.31B 4.22B 182B
Net Debt -761M -657M -619M -564M -1.05B -71.9B -1.06B -7.32B -2.84B -36.76B -2.86B -2.8B -121B -1.06B -916M -863M -786M -1.47B -100B -1.48B -10.21B -3.96B -51.27B -3.99B -3.9B -168B
Logo DexCom, Inc.
DexCom, Inc. specializes in the design, manufacture and marketing of continuous glucose monitoring (CGM) systems for people with diabetes and healthcare providers. The company provides an implantable device for continuous measurement of blood glucose levels and an external transmitter to which the sensor transmits glucose levels at specified intervals. The United States accounts for 71.5% of net sales.
Employees
11,050
Date Price Change Volume
03/09/26 US$89.56 -0.15% 273,721
02/09/26 US$89.69 -0.50% 1,918,398
01/09/26 US$90.14 -1.01% 2,151,646
31/08/26 US$91.06 +0.26% 2,999,449
28/08/26 US$90.82 +1.71% 2,546,957
Trader
Investor
Global
Quality
ESG MSCI
BBB
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
28
Last Close Price
89.69USD
Average target price
94.12USD
Spread / Average Target
+4.94%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. DXCM Stock